Troikaa Pharmaceuticals Ltd.
About Troikaa Pharmaceuticals Ltd.
Certifications
Categories
-
IN
-
2022On CPHI since
-
2Certificates
-
1000 - 4999Employees
Company types
Primary activities
Meet us at
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Troikaa Pharmaceuticals Ltd. (5)
-
Product Levetiracetam Injection 100 mg/ml
Indication:
For treatment & control of seizures
Available as:
100 mg/ ml (5ml ampoule) -
Product Midazolam Injection 5 mg/ml
Indication:
For preoperative sedation, conscious sedation prior to short diagnostic procedures, ICU sedation and induction of general anaesthesia prior to administration of other anaesthetic agents
Available as:
5 mg/ ml (3 ml & 10 ml ampoule) -
Product Ondansetron Injection 2 mg/ml
Indication:
To prevent nausea and vomiting
Available as:
2 mg/ ml (2 ml & 4 ml ampoule) -
Product Propofol Injection 10 mg/ml (1% w/v)
Indication:
For induction & maintenance of anesthesia
Available as:
10 mg/ml (20 ml & 50 ml vial)
-
Product Sevoflurane API, Propofol API and Glycofurol excipient
High quality APIs, Minimum impurities offered by Troikaa Pharmachem Pvt. Ltd.; a wholly owned subsidiary of Troikaa Pharmeceuticals Ltd. • Sevoflurane • Propofol • Remifentanyl • Ketamin • Dexmedetomidine • Midazolam • Rocuronium Bromide • Dequalinium • Glycofurol (Excipient)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance